Suchergebnisse - "O3J8G9O825"

PubPharm (893)

1

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

2

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults

enthalten in: British journal of clinical pharmacology | 2024

von Zhang, Y. | Joshi, S. | Yazdani, P. | +6

3

A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical Institute, Bucharest, Romania

enthalten in: Medical science monitor : international medical journal of experimental and clinical research | 2022

von Bacinschi, X. | Popescu, G. | Zgura, A. | +7

4

Drug-Drug Interactions With Cyclosporine in the Anti-Hepatitis C Viral PrOD Combination Regimen of Paritaprevir/Ritonavir-Ombitasvir and Dasabuvir in Organ Transplant Recipients With Severe Hepatic Fibrosis or Cirrhosis

enthalten in: Therapeutic drug monitoring | 2022

von Huang, Y. | Huang, Y. | Wu, T. | +4

5

Glycemic Control in Patients Undergoing Treatment With Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir for Chronic Hepatitis C Infection

enthalten in: In vivo (Athens, Greece) | 2022

von Bacinschi, X. | Mercan-Stanciu, A. | Toma, L. | +6

6

hsa-miR-17-5p : A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection

enthalten in: Current microbiology | 2022

von Öksüz, Z. | Üçbilek, E. | Serin, M. | +3

7

Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders

enthalten in: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology | 2022

von Sonsuz, A. | Bozcan, S. | Hatemi, �. | +5

8

Combined Use of Calcium-channel Blockers With Ombitasvir/Paritaprevir/Ritonavir Exacerbates Peripheral Edema in Elderly Japanese Patients

enthalten in: Anticancer research | 2022

von Sadaka, Y. | Soda, M. | Hori, A. | +6

9

High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4 : Real world results

enthalten in: Journal of medical virology | 2022

von El Kassas, M. | Alboraie, M. | Omar, H. | +8

10

'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant

enthalten in: Annals of hepatology | 2021

von Fabrizi, F. | Alonso, C. | Palazzo, A. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[90]